139 related articles for article (PubMed ID: 19419757)
1. Cancer procoagulant (CP) analysis in human WM 115 malignant melanoma cells in vitro.
Kaplinska K; Rozalski M; Krajewska U; Mielicki WP
Thromb Res; 2009 Jul; 124(3):364-7. PubMed ID: 19419757
[TBL] [Abstract][Full Text] [Related]
2. Cancer procoagulant in human tumor cells: evidence from melanoma patients.
Donati MB; Gambacorti-Passerini C; Casali B; Falanga A; Vannotti P; Fossati G; Semeraro N; Gordon SG
Cancer Res; 1986 Dec; 46(12 Pt 1):6471-4. PubMed ID: 3536081
[TBL] [Abstract][Full Text] [Related]
3. [Cancer procoagulant (CP)].
Szajda SD; Darewicz B; Gorzel M; Zalewska B; Skrzydlewski Z; Kudelski J; Domel T
Przegl Lek; 2005; 62(3):169-72. PubMed ID: 16171148
[TBL] [Abstract][Full Text] [Related]
4. Direct analysis reveals an absence of gamma-carboxyglutamic acid in cancer procoagulant from human tissues.
Kaplinska K; Mielicki WP
Blood Coagul Fibrinolysis; 2009 Jul; 20(5):315-20. PubMed ID: 19448531
[TBL] [Abstract][Full Text] [Related]
5. Different expression of procoagulant activity in human cancer cells cultured "in vitro" or in cells isolated from human tumor tissues.
Zucchella M; Pacchiarini L; Tacconi F; Saporiti A; Grignani G
Thromb Haemost; 1993 Apr; 69(4):335-8. PubMed ID: 8497845
[TBL] [Abstract][Full Text] [Related]
6. Properties of proteins in cancer procoagulant preparations that are detected by anti-tissue factor antibodies.
Raasi S; Mielicki WP; Gordon SG; Korte W
Arch Biochem Biophys; 2004 Aug; 428(2):131-5. PubMed ID: 15246868
[TBL] [Abstract][Full Text] [Related]
7. Simultaneous tissue factor expression and phosphatidylserine exposure account for the highly procoagulant pattern of melanoma cell lines.
Kirszberg C; Lima LG; Da Silva de Oliveira A; Pickering W; Gray E; Barrowcliffe TW; Rumjanek VM; Monteiro RQ
Melanoma Res; 2009 Oct; 19(5):301-8. PubMed ID: 19550359
[TBL] [Abstract][Full Text] [Related]
8. Cancer procoagulant: a factor X activator, tumor marker and growth factor from malignant tissue.
Gordon SG; Mielicki WP
Blood Coagul Fibrinolysis; 1997 Mar; 8(2):73-86. PubMed ID: 9518049
[TBL] [Abstract][Full Text] [Related]
9. Discrepancy between tissue factor activity and tissue factor expression in endotoxin-induced monocytes is associated with apoptosis and necrosis.
Henriksson CE; Klingenberg O; Ovstebø R; Joø GB; Westvik AB; Kierulf P
Thromb Haemost; 2005 Dec; 94(6):1236-44. PubMed ID: 16411400
[TBL] [Abstract][Full Text] [Related]
10. Effect of cancer procoagulant (CP) on the growth and adhesion of MCF-7 cells to vitronectin in vitro.
Kamocka M; Rózalski M; Krajewska U; Wierzbicki R; Mielicki WP
Cancer Lett; 2005 May; 222(1):89-94. PubMed ID: 15837545
[TBL] [Abstract][Full Text] [Related]
11. Malignant transformation in melanocytes is associated with increased production of procoagulant microvesicles.
Lima LG; Oliveira AS; Campos LC; Bonamino M; Chammas R; Werneck C; Vicente CP; Barcinski MA; Petersen LC; Monteiro RQ
Thromb Haemost; 2011 Oct; 106(4):712-23. PubMed ID: 21800005
[TBL] [Abstract][Full Text] [Related]
12. Effect of divalent ions on the activity of cancer procoagulant.
Mielicki WP; Kozwich DL; Kramer LC; Gordon SG
Arch Biochem Biophys; 1994 Oct; 314(1):165-70. PubMed ID: 7944389
[TBL] [Abstract][Full Text] [Related]
13. Cancer procoagulant--CP.
Rucińska M; Gacko M; Skrzydlewski Z
Rocz Akad Med Bialymst; 1997; 42 Suppl 1():110-7. PubMed ID: 9337529
[TBL] [Abstract][Full Text] [Related]
14. Procoagulant activity associated with plasma membrane vesicles shed by cultured tumor cells.
Dvorak HF; Van DeWater L; Bitzer AM; Dvorak AM; Anderson D; Harvey VS; Bach R; Davis GL; DeWolf W; Carvalho AC
Cancer Res; 1983 Sep; 43(9):4434-42. PubMed ID: 6347372
[TBL] [Abstract][Full Text] [Related]
15. Hemoglobin binds melanoma cell tissue factor and enhances its procoagulant activity.
Siddiqui FA; Francis JL
Blood Coagul Fibrinolysis; 2002 Apr; 13(3):173-80. PubMed ID: 11943929
[TBL] [Abstract][Full Text] [Related]
16. Rat prostate tumors express cancer procoagulant, an activator of coagulation factor X.
Kamocka M; Pollard M; Suckow M; Mielicki WP; Rosen ED
Comp Med; 2008 Jun; 58(3):282-6. PubMed ID: 18589871
[TBL] [Abstract][Full Text] [Related]
17. Factor X-activating activity from Guerin epithelioma.
Mielicki W; Wierzbicki R
Neoplasma; 1988; 35(3):279-84. PubMed ID: 3405336
[TBL] [Abstract][Full Text] [Related]
18. Tissue factor and cancer procoagulant expressed by glioma cells participate in their thrombin-mediated proliferation.
Ogiichi T; Hirashima Y; Nakamura S; Endo S; Kurimoto M; Takaku A
J Neurooncol; 2000; 46(1):1-9. PubMed ID: 10896200
[TBL] [Abstract][Full Text] [Related]
19. Comparison of procoagulant activities in extracts of normal and malignant human tissue.
Gordon SG; Franks JJ; Lewis BJ
J Natl Cancer Inst; 1979 Apr; 62(4):773-6. PubMed ID: 285292
[TBL] [Abstract][Full Text] [Related]
20. Cancer procoagulant in acute non lymphoid leukemia: relationship of enzyme detection to disease activity.
Donati MB; Falanga A; Consonni R; Alessio MG; Bassan R; Buelli M; Borin L; Catani L; Pogliani E; Gugliotta L
Thromb Haemost; 1990 Aug; 64(1):11-6. PubMed ID: 2274915
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
